Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study

Volume: 8, Issue: 11, Pages: 2369 - 2376
Published: Nov 1, 2010
Abstract
SummaryBackground: Terutroban is a selective prostaglandin endoperoxide (TP) receptor antagonist with antithrombotic, antivasoconstrictive and antiatherosclerotic properties and is currently in development for long‐term cardiovascular secondary prevention. Objectives: TAIPAD is an international, double‐blind, randomized controlled study comparing the effects of five dosages of oral terutroban vs. aspirin and placebo on platelet aggregation in...
Paper Details
Title
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study
Published Date
Nov 1, 2010
Volume
8
Issue
11
Pages
2369 - 2376
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.